semaglutide 1.25 mg dose Weight Loss Dosage Chart Obesema(Semaglutide) 0.25mg Injection (1 Multi-dose

In global clinical GLP-1 therapy guidelines, the 0.25 mg strength is strictly defined as the **initiation or starter phase**. It is not meant to serve as a long-term maintenance dose. The primary objective of this introductory volume is to gently introduce Semaglutide to your body's receptors. Patients typically remain on this baseline strength for exactly 4 weeks. Once a safe, comfortable tolerance is established, your healthcare provider will transition you to the next step-up dose (0.5mg) to steadily accelerate your weight loss momentum

Personalizing obesity assessment and care planning in primary care: patient experience and outcomes in everyday life and health

It means 93-95% of people who start treatment can tolerate it well enough to continue, even if they experience some side effects along the way

If youre thinking about the overall treatment plan, you can also see if you qualify for a personalized program

doi: 10.1111/j.1476-5381.2011.01781.x